MedTrace Logo

Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

NCT07353918 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-01-21

No results posted yet for this study

Summary

This study is an invite only study looking at the effects of Low-Intensity Focused Ultrasound (LIFU) on epilepsy patients with implanted electrodes under the care of Dr. Shah.

Conditions

  • Epilepsy (Treatment Refractory)
  • Epilepsy Comorbidities

Interventions

DEVICE

Low-intensity Focused Ultrasound

focused ultrasound transducer.

DEVICE

Sham

Sham application of LIFU - energy blocked. Targeted to the same target as intervention.

Sponsors & Collaborators

  • Carilion Clinic

    lead OTHER

Principal Investigators

  • Aashit Shah, MD · Carilion Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-13
Primary Completion
2027-12-31
Completion
2028-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07353918 on ClinicalTrials.gov